Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2019 | 952 | 0.74 | Why? |
Reverse Transcriptase Inhibitors | 1 | 2019 | 309 | 0.66 | Why? |
Drugs, Investigational | 1 | 2019 | 198 | 0.61 | Why? |
HIV Infections | 6 | 2020 | 11620 | 0.37 | Why? |
Sarcoma, Kaposi | 2 | 2019 | 97 | 0.33 | Why? |
Obsessive-Compulsive Disorder | 1 | 2021 | 486 | 0.26 | Why? |
Conjunctival Diseases | 1 | 2020 | 32 | 0.21 | Why? |
Breast Neoplasms | 1 | 2019 | 3633 | 0.21 | Why? |
Brucella melitensis | 1 | 2019 | 10 | 0.20 | Why? |
HLA-C Antigens | 1 | 2021 | 195 | 0.20 | Why? |
Brucellosis | 1 | 2019 | 49 | 0.18 | Why? |
HIV Fusion Inhibitors | 1 | 2019 | 80 | 0.18 | Why? |
Corneal Diseases | 1 | 2020 | 172 | 0.18 | Why? |
Trace Elements | 1 | 2021 | 284 | 0.17 | Why? |
Autoimmune Diseases | 1 | 2021 | 1996 | 0.17 | Why? |
Eye | 1 | 2020 | 374 | 0.16 | Why? |
Psoriasis | 2 | 2020 | 1739 | 0.15 | Why? |
Lymphoma, Non-Hodgkin | 1 | 2019 | 403 | 0.15 | Why? |
Arthritis, Psoriatic | 1 | 2020 | 625 | 0.14 | Why? |
Skin Diseases, Viral | 1 | 2020 | 436 | 0.13 | Why? |
Environmental Microbiology | 1 | 2019 | 575 | 0.13 | Why? |
Skin Diseases | 1 | 2020 | 2509 | 0.13 | Why? |
Atherosclerosis | 1 | 2021 | 768 | 0.12 | Why? |
Cytomegalovirus | 1 | 2018 | 600 | 0.12 | Why? |
Acquired Immunodeficiency Syndrome | 1 | 2019 | 533 | 0.12 | Why? |
Cytomegalovirus Infections | 1 | 2018 | 667 | 0.11 | Why? |
Anti-HIV Agents | 2 | 2019 | 2209 | 0.10 | Why? |
Carcinoma, Hepatocellular | 1 | 2017 | 1222 | 0.08 | Why? |
Liver | 1 | 2021 | 4007 | 0.08 | Why? |
Hepatitis C | 1 | 2017 | 1514 | 0.08 | Why? |
Biological Products | 1 | 2020 | 2331 | 0.08 | Why? |
Erythema | 1 | 2020 | 400 | 0.07 | Why? |
Liver Neoplasms | 1 | 2017 | 1666 | 0.07 | Why? |
Liver Diseases | 1 | 2021 | 2698 | 0.07 | Why? |
CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.07 | Why? |
HIV-1 | 1 | 2019 | 3365 | 0.06 | Why? |
Receptors, KIR2DL1 | 1 | 2021 | 23 | 0.06 | Why? |
Diagnosis, Differential | 2 | 2021 | 7220 | 0.06 | Why? |
Phosphorus | 1 | 2021 | 80 | 0.05 | Why? |
Epidemics | 1 | 2021 | 6407 | 0.05 | Why? |
Matrix Metalloproteinases | 1 | 2021 | 131 | 0.05 | Why? |
Immunosuppressive Agents | 1 | 2019 | 6331 | 0.05 | Why? |
Receptors, KIR | 1 | 2021 | 167 | 0.05 | Why? |
Virus Internalization | 1 | 2019 | 7921 | 0.05 | Why? |
Humans | 21 | 2021 | 930598 | 0.05 | Why? |
Venous Thromboembolism | 1 | 2018 | 4273 | 0.05 | Why? |
Hospitals | 1 | 2019 | 11793 | 0.05 | Why? |
Sicily | 1 | 2019 | 153 | 0.05 | Why? |
Magnesium | 1 | 2021 | 290 | 0.05 | Why? |
Contraceptives, Oral, Hormonal | 1 | 2018 | 42 | 0.04 | Why? |
Copper | 1 | 2021 | 288 | 0.04 | Why? |
Gram-Positive Bacteria | 1 | 2019 | 230 | 0.04 | Why? |
Coinfection | 1 | 2017 | 6820 | 0.04 | Why? |
Risk Factors | 4 | 2020 | 71621 | 0.04 | Why? |
Candida albicans | 1 | 2019 | 217 | 0.04 | Why? |
Incidence | 1 | 2019 | 25622 | 0.04 | Why? |
Cross Infection | 1 | 2019 | 8675 | 0.04 | Why? |
T-Lymphocytes, Helper-Inducer | 1 | 2020 | 497 | 0.04 | Why? |
Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
Selenium | 1 | 2021 | 412 | 0.04 | Why? |
Calcium | 1 | 2021 | 708 | 0.04 | Why? |
Cardiovascular Diseases | 1 | 2021 | 11497 | 0.04 | Why? |
Disease Transmission, Infectious | 1 | 2019 | 9044 | 0.04 | Why? |
Iron | 1 | 2021 | 619 | 0.04 | Why? |
Norovirus | 1 | 2019 | 294 | 0.04 | Why? |
Liver Function Tests | 1 | 2021 | 1325 | 0.03 | Why? |
Gram-Negative Bacteria | 1 | 2019 | 473 | 0.03 | Why? |
CD4 Lymphocyte Count | 1 | 2019 | 1517 | 0.03 | Why? |
Zinc | 1 | 2021 | 817 | 0.03 | Why? |
HIV | 1 | 2020 | 1116 | 0.03 | Why? |
Male | 8 | 2021 | 367725 | 0.03 | Why? |
Virion | 1 | 2021 | 1444 | 0.03 | Why? |
Sputum | 1 | 2020 | 1720 | 0.03 | Why? |
Biopsy | 1 | 2021 | 2811 | 0.03 | Why? |
Female | 7 | 2021 | 380317 | 0.03 | Why? |
Coronavirus Infections | 4 | 2021 | 253789 | 0.03 | Why? |
Coronavirus | 1 | 2021 | 18339 | 0.03 | Why? |
Lymphocyte Activation | 1 | 2021 | 2742 | 0.03 | Why? |
Disease Outbreaks | 1 | 2019 | 27595 | 0.03 | Why? |
Aged, 80 and over | 4 | 2021 | 88759 | 0.03 | Why? |
Interferon-gamma | 1 | 2020 | 2711 | 0.03 | Why? |
Adolescent | 2 | 2021 | 86841 | 0.03 | Why? |
Drug Resistance, Bacterial | 1 | 2019 | 1414 | 0.02 | Why? |
Risk | 1 | 2021 | 5288 | 0.02 | Why? |
Epithelial Cells | 1 | 2021 | 3508 | 0.02 | Why? |
Skin | 1 | 2020 | 2096 | 0.02 | Why? |
Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
Child | 2 | 2021 | 70012 | 0.02 | Why? |
Feces | 1 | 2020 | 4235 | 0.02 | Why? |
Lopinavir | 1 | 2021 | 4308 | 0.02 | Why? |
Genetic Predisposition to Disease | 1 | 2021 | 4027 | 0.02 | Why? |
Ritonavir | 1 | 2021 | 4212 | 0.02 | Why? |
Adult | 5 | 2021 | 244371 | 0.02 | Why? |
Middle Aged | 5 | 2021 | 270681 | 0.02 | Why? |
Smoking | 1 | 2018 | 3358 | 0.02 | Why? |
Aged | 4 | 2021 | 215776 | 0.02 | Why? |
Comorbidity | 2 | 2018 | 34796 | 0.02 | Why? |
Infectious Disease Transmission, Vertical | 1 | 2020 | 5164 | 0.02 | Why? |
Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
Antineoplastic Agents | 1 | 2017 | 3550 | 0.01 | Why? |
Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
Animals | 2 | 2020 | 78931 | 0.01 | Why? |
Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
Young Adult | 2 | 2020 | 93724 | 0.01 | Why? |
Quality of Life | 1 | 2019 | 9820 | 0.01 | Why? |
Antiviral Agents | 2 | 2021 | 41703 | 0.01 | Why? |
Italy | 1 | 2021 | 38444 | 0.01 | Why? |
SARS Virus | 1 | 2020 | 13021 | 0.01 | Why? |
Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
Retrospective Studies | 1 | 2019 | 105322 | 0.01 | Why? |